1
Clinical Trials associated with JNJ-70075200A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of JNJ-70075200 in Healthy Participants
The purpose of the study is to evaluate safety and tolerability of JNJ-70075200 compared with placebo after administration of single ascending doses of JNJ-70075200 as oral solution (Part 1); multiple ascending doses of JNJ-70075200, administered as oral solution over 14 consecutive days (Part 2); and the option of a single dose of JNJ-70075200 administered as an oral solid formulation (Part 3).
100 Clinical Results associated with JNJ-70075200
100 Translational Medicine associated with JNJ-70075200
100 Patents (Medical) associated with JNJ-70075200
100 Deals associated with JNJ-70075200